Topics
Glioblastoma | Diagnosis | Differentiation
Home > Publications > Topics > Glioblastoma > Diagnosis > Differentiation
Chuthip
P, Sitthinamsuwan B, Witthiwej T, Tansirisithikul C, Khumpalikit
I, Nunta-Aree S.
Predictors
for the Differentiation between Glioblastoma, Primary Central
Nervous System Lymphoma, and Metastasis in Patients with a
Solitary Enhancing Intracranial Mass.
Asian
J Neurosurg.
2024 Jun 6;19(2):186-201. doi:
10.1055/s-0044-1787051. PMID:
38974428. Observational study. ˍ
Zhang Y, Luo X, Zhu Y, Zhang Q, Liu B.
Differentiation
between primary central nervous system lymphomas and gliomas
according to pharmacokinetic parameters derived from dynamic
contrast-enhanced magnetic resonance imaging.
Heliyon.
2024 Jun 6;10(12):e32619. doi:
10.1016/j.heliyon.2024.e32619. PMID:
38952379.
Observational study. ˍ
Würtemberger
U, Diebold M, Rau A, Akgün V, Becker L, Beck J, Reinacher PC,
Taschner CA, Reisert M, Fehrenbacher L, Erny D, Scherer F,
Hohenhaus M, Urbach H, Demerath T.
Advanced
diffusion imaging reveals microstructural characteristics of
primary CNS lymphoma, allowing differentiation from glioblastoma.
Neurooncol
Adv.
2024 Jun 8;6(1):vdae093. doi:
10.1093/noajnl/vdae093. PMID:
38946879. Observational study. ˍ
Khalaj K, Jacobs MA, Zhu JJ, Esquenazi Y, Hsu S, Tandon N,
Akhbardeh A, Zhang X, Riascos R, Kamali A.
The
Use of Apparent Diffusion Coefficient Values for
Differentiating Bevacizumab-Related
Cytotoxicity from Tumor Recurrence and
Radiation Necrosis in Glioblastoma.
Cancers
(Basel). 2024 Jul 2;16(13):2440. doi:
10.3390/cancers16132440. PMID:
39001500.
Observational study. ˍ